{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:29:16Z","timestamp":1770722956928,"version":"3.49.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","sempedneurjnl.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.spen.2017.10.005","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T16:34:34Z","timestamp":1507998874000},"page":"301-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Bone Health and Endocrine Comorbidities in Pediatric Epilepsy"],"prefix":"10.1016","volume":"24","author":[{"given":"Nancy A.","family":"McNamara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin Marie Fedak","family":"Romanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee A.","family":"Shellhaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2017.10.005_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"NEJM"},{"key":"10.1016\/j.spen.2017.10.005_bib2","year":"2014","journal-title":"American Academy of Neurology Quality Measurement Manual"},{"key":"10.1016\/j.spen.2017.10.005_bib3","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3390\/ijms17081242","article-title":"The impact of anti-epileptic drugs on growth and bone metabolism","volume":"17","author":"Fan","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"6 Suppl","key":"10.1016\/j.spen.2017.10.005_bib4","doi-asserted-by":"crossref","first-page":"1689S","DOI":"10.1093\/ajcn\/80.6.1689S","article-title":"Overview of general physiologic features and functions of vitamin D","volume":"80","author":"DeLuca","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.spen.2017.10.005_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1542\/peds.2007-1894","article-title":"Vitamin D deficiency in children and its management: Review of current knowledge and recommendations","volume":"122","author":"Misra","year":"2008","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.spen.2017.10.005_bib6","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.spen.2017.10.005_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMcp1009570","article-title":"Clinical practice. Vitamin D insufficiency","volume":"364","author":"Rosen","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.spen.2017.10.005_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pediatrneurol.2009.12.005","article-title":"Vitamin D and bone health among children with epilepsy","volume":"42","author":"Shellhaas","year":"2010","journal-title":"Pediatr Neurol"},{"issue":"8","key":"10.1016\/j.spen.2017.10.005_bib9","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.eplepsyres.2014.06.008","article-title":"Low vitamin D levels are common in patients with epilepsy","volume":"108","author":"Teagarden","year":"2014","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.spen.2017.10.005_bib10","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1542\/peds.2014-2173","article-title":"Optimizing bone health in children and adolescents","volume":"134","author":"Golden","year":"2014","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.spen.2017.10.005_bib11","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2748","article-title":"Trends in the diagnosis of vitamin D deficiency","volume":"139","author":"Basatemur","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.10.005_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1515\/jpem-2013-0246","article-title":"Prevalence and risk of deficiency and inadequacy of 25-hydroxyvitamin D in US children: NHANES 2003-2006","volume":"27","author":"Karalius","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.spen.2017.10.005_bib13","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2012-1711","article-title":"Prevalence of vitamin D deficiency among overweight and obese US children","volume":"131","author":"Turner","year":"2013","journal-title":"Pediatrics"},{"issue":"Suppl 3","key":"10.1016\/j.spen.2017.10.005_bib14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.yebeh.2004.06.010","article-title":"Defining the problem: psychiatric and behavioral comorbidity in children and adolescents with epilepsy","volume":"5","author":"Pellock","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.spen.2017.10.005_bib15","first-page":"283","article-title":"Psychiatric comorbidity in epilepsy","volume":"3","author":"Beyenburg","year":"2005","journal-title":"Bull Soc Sci Med Grand Duche Luxemb"},{"issue":"1","key":"10.1016\/j.spen.2017.10.005_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yebeh.2008.08.015","article-title":"Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment","volume":"14","author":"Ekinci","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.spen.2017.10.005_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1159\/000134382","article-title":"Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer\u2019s disease","volume":"25","author":"Oudshoorn","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"10.1016\/j.spen.2017.10.005_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.abb.2006.12.018","article-title":"Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function","volume":"460","author":"Przybelski","year":"2007","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"10.1016\/j.spen.2017.10.005_bib19","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/01.JGP.0000240986.74642.7c","article-title":"Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults","volume":"14","author":"Wilkins","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.spen.2017.10.005_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1755-7682-3-29","article-title":"Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey","volume":"3","author":"Ganji","year":"2010","journal-title":"Int Arch Med"},{"issue":"3","key":"10.1016\/j.spen.2017.10.005_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12016-016-8577-0","article-title":"Vitamin D deficiency and rheumatoid arthritis","volume":"52","author":"Ishikawa","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1016\/j.spen.2017.10.005_bib22","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/nu7043011","article-title":"Vitamin D and 1,25 (OH)2D regulation of T cells","volume":"7","author":"Cantorna","year":"2016","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.spen.2017.10.005_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11154-016-9405-9","article-title":"Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept","volume":"18","author":"Altieri","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"10.1016\/j.spen.2017.10.005_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/HPC.0000000000000122","article-title":"Vitamin D deficiency, supplementation, and cardiovascular health","volume":"16","author":"Trehan","year":"2017","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.spen.2017.10.005_bib25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jsbmb.2015.04.006","article-title":"Update on the vitamin D and omega-3 trial (VITAL)","author":"Pradhan","year":"2016","journal-title":"J Steroid Biochem Mol Biol 155(Pt B)"},{"key":"10.1016\/j.spen.2017.10.005_bib26","article-title":"Vitamin D levels in childhood and adolescence and cardiovascular risk factors in a cohort of healthy Australian children","volume":"14","author":"Ke","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.spen.2017.10.005_bib27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yebeh.2004.02.005","article-title":"Antiepileptic drugs and reduced bone mineral density","volume":"5","author":"Ali","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.spen.2017.10.005_bib28","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.58.9.1348","article-title":"Effect of antiepileptic drugs on bone density in ambulatory patients","volume":"58","author":"Farhat","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.10.005_bib29","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/epi.12351","article-title":"Prevention of bone loss and vertebral fractures in patients with chronic epilepsy\u2014Antiepileptic drug and osteoporosis prevention trial","volume":"54","author":"Lazzari","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2017.10.005_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/nu5010111","article-title":"Vitamin D effects of skeletal and extraskeletal health and the need for supplementation","volume":"5","author":"Wacker","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.spen.2017.10.005_bib31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.seizure.2010.04.013","article-title":"Fractures in epilepsy children","volume":"19","author":"Gniathkowska-Nowakowska","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.spen.2017.10.005_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1531-8249(200003)47:3<385::AID-ANA18>3.0.CO;2-W","article-title":"Increased bone turnover in epileptic patients treated with carbamazepine","volume":"47","author":"Verrotti","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.10.005_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.seizure.2012.10.002","article-title":"Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: cohort study using the general practice research database","volume":"22","author":"Nicholas","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.spen.2017.10.005_bib34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.spen.2007.08.006","article-title":"Bone consequences of epilepsy and antiepileptic medications","volume":"14","author":"Samaniego","year":"2007","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.10.005_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0013-9580.2005.23804.x","article-title":"Incidence of fractures among epilepsy patients: A population-based retrospective cohort study in the General Practice Research Database","volume":"46","author":"Souverein","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2017.10.005_bib36","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.63.10_suppl_4.S24","article-title":"Metabolic concerns associated with antiepileptic medications","volume":"63","author":"Sheth","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.10.005_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s13760-017-0775-x","article-title":"Potential risk factors for vitamin D levels in medium- and long-term use of antiepileptic drugs in childhood","volume":"111","author":"Yildiz","year":"2017","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.spen.2017.10.005_bib38","first-page":"37","article-title":"Long-term anticonvulsant therapy leads to low bone mineral density\u2014evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells","volume":"108","author":"Feldkamp","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.spen.2017.10.005_bib39","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1528-1167.2006.00478.x","article-title":"Physical activity in children\/teens with epilepsy compared with that in their siblings without epilepsy","volume":"47","author":"Wong","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2017.10.005_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00198-014-2840-0","article-title":"Bone mineral density and vitamin D status in ambulatory and non-ambulatory children with cerebral palsy","volume":"26","author":"Finbraten","year":"2015","journal-title":"Osteoporos"},{"issue":"3","key":"10.1016\/j.spen.2017.10.005_bib41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/jcem-73-3-555","article-title":"Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence","volume":"73","author":"Bonjour","year":"1991","journal-title":"J Clin Endocr Metab"},{"issue":"Suppl 2","key":"10.1016\/j.spen.2017.10.005_bib42","article-title":"Adolescent issues in epilepsy","volume":"17","author":"Sheth","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.10.005_bib43","first-page":"985","article-title":"Lifetime fracture risk: An approach to hip fracture risk assessment based on bone mineral density and age","volume":"41","author":"Melton","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.spen.2017.10.005_bib44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/1047-2797(94)00100-8","article-title":"Lifetime occupational physical activity and risk of hip fracture in women","volume":"5","author":"Jaglal","year":"1995","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.spen.2017.10.005_bib45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women: study of Osteoporotic Fractures Research Group","volume":"332","author":"Cummings","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2017.10.005_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0020-1383(95)00189-1","article-title":"Incidence of five common fractures in an institutionalized epileptic population","volume":"27","author":"Desai","year":"1996","journal-title":"Injury"},{"key":"10.1016\/j.spen.2017.10.005_bib47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-0404.1999.tb00675.x","article-title":"Fracture risk is increased in epilepsy","volume":"99","author":"Vestergaard","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.spen.2017.10.005_bib48","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s001980170031","article-title":"Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: A systematic review of the literature","volume":"12","author":"Espallargues","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.spen.2017.10.005_bib49","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1531-8249(199904)45:4<444::AID-ANA5>3.0.CO;2-6","article-title":"Valproate induced hyperandrogenism during pubertal maturation in girls with epilepsy","volume":"45","author":"Vanionp\u00e4\u00e4","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.10.005_bib50","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bone.2014.04.018","article-title":"Association between use of antiepileptic drugs and fracture risk: A systematic review and meta-analysis","volume":"64","author":"Shen","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.spen.2017.10.005_bib51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/1745509X.1.1.147","article-title":"Antiepileptic durgs and their impact on balance","author":"Fife","year":"2005","journal-title":"Aging Health"},{"key":"10.1016\/j.spen.2017.10.005_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bdj.4804977","article-title":"Abnormal skeletal and dental growth in epileptic children","volume":"154","author":"Robinson","year":"1983","journal-title":"Br Dent J"},{"key":"10.1016\/j.spen.2017.10.005_bib53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1528-1157.1997.tb01733.x","article-title":"Patients\u2019 experience as a result of epilepsy","volume":"38","author":"Beck","year":"1997","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.spen.2017.10.005_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF03262662","article-title":"Oral health of children with intractable epilepsy attending the UK National Centre for Young People with Epilepsy","volume":"10","author":"Pervical","year":"2009","journal-title":"Euro Arch Paed Dent"},{"issue":"11","key":"10.1016\/j.spen.2017.10.005_bib55","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1212\/WNL.0b013e3182152844","article-title":"Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children","volume":"76","author":"Arya","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.10.005_bib56","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity","volume":"43","author":"Pylv\u00e4nen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2017.10.005_bib57","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archneur.58.9.1369","article-title":"Practice parameters of neurologists regarding bone and mineral effects of antiepileptic drug therapy","volume":"58","author":"Valmadrid","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.spen.2017.10.005_bib58","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneur.59.5.781","article-title":"Antiepileptic drug-induced bone loss in young male patients who have seizures","volume":"59","author":"Andress","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.spen.2017.10.005_bib59","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/adc.88.9.795","article-title":"Bone densitometry in children assessed by dual\u00a0x\u00a0ray absorptiometry: Uses and pitfalls","volume":"88","author":"Fewtrell","year":"2003","journal-title":"Arch Dis Childhood"},{"key":"10.1016\/j.spen.2017.10.005_bib60","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00223-001-0043-0","article-title":"Glucocorticoids and bone: some general remarks and some specialobservations in pediatric patients","volume":"70","author":"Bianchi","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.spen.2017.10.005_bib61","unstructured":"Centers for Disease control and Prevention. Childhood Obesity Facts. Available at: https:\/\/www.cdc.gov\/obesity\/data\/childhood.html. Accessed June 23, 2017"},{"key":"10.1016\/j.spen.2017.10.005_bib62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2007.01402.x","article-title":"Weight issues for people with epilepsy\u2014A review","volume":"9","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia 48: S"},{"issue":"5","key":"10.1016\/j.spen.2017.10.005_bib63","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1515\/JPEM.2005.18.5.423","article-title":"Endocrine and metabolic changes in epileptic patients receiving valproic acid","volume":"18","author":"Verrotti","year":"2005","journal-title":"J Ped Endocrin Metab"},{"issue":"4","key":"10.1016\/j.spen.2017.10.005_bib64","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.yebeh.2010.01.013","article-title":"The potential role of physical exercise in the treatment of epilepsy","volume":"17","author":"Arida","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.spen.2017.10.005_bib65","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.1968.03150060065016","article-title":"Convulsive disorders and participation in sports and physical education","volume":"206","year":"1968","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.spen.2017.10.005_bib66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.seizure.2014.09.015","article-title":"Epilepsy and physical exercise","volume":"25","author":"Pimentel","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.spen.2017.10.005_bib67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0404.1984.tb00804.x","article-title":"Weight gain during treatment with valproate","volume":"70","author":"Dinesen","year":"1984","journal-title":"Acta Neural Scand"},{"key":"10.1016\/j.spen.2017.10.005_bib68","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/088307389901400802","article-title":"Risk of excessive weight gain in epileptic children treated with valproate","volume":"14","author":"Novak","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.10.005_bib69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0317167100021879","article-title":"Weight gain in epileptic patients during treatment with valproic acid: A retrospective study","volume":"24","author":"Corman","year":"1997","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.spen.2017.10.005_bib70","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.53.1.230","article-title":"Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid","volume":"53","author":"Verrotti","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.10.005_bib71","first-page":"579","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy","volume":"41","author":"Isoj\u00e4rvi","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.10.005_bib72","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2337\/diab.45.7.988","article-title":"Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men","volume":"45","author":"Segal","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.spen.2017.10.005_bib73","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diab.45.5.699","article-title":"Acute and chronic effect of insulin on leptin production in humans: studies in vivo and in vitro","volume":"45","author":"Kolaczynski","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.spen.2017.10.005_bib74","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410430406","article-title":"Valproate, lamotrigine and insulin mediated risks in women with epilepsy","volume":"43","author":"Isoj\u00e4rvi","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.10.005_bib75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/088307380201700405","article-title":"Insulin resistance in epileptic girls who gain weight after therapy with valproic acid","volume":"17","author":"Verrotti","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.10.005_bib76","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1177\/0883073807307096","article-title":"The role of ghrelin in weight gain and growth in epileptic children using valproate","volume":"22","author":"Gungor","year":"2007","journal-title":"Journal Child Neurol"},{"issue":"3","key":"10.1016\/j.spen.2017.10.005_bib77","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1542\/peds.103.3.588","article-title":"The Effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy","volume":"103","author":"Rayyta","year":"1999","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.spen.2017.10.005_bib78","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1046\/j.1528-1157.2001.416800.x","article-title":"Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy","volume":"42","author":"Guo","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2017.10.005_bib79","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1157.1999.tb01595.x","article-title":"Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism","volume":"40","author":"Eir\u00eds-Pu\u00f1al","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2017.10.005_bib80","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.291.2.228","article-title":"Subclinical thyroid disease: scientific review and guidelines for diagnosis and management","volume":"291","author":"Surks","year":"2004","journal-title":"J AM Med Assoc"},{"issue":"1","key":"10.1016\/j.spen.2017.10.005_bib81","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.seizure.2013.09.006","article-title":"The effect of antiepileptic drugs on thyroid function in children","volume":"23","author":"Yilmaz","year":"2014","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.spen.2017.10.005_bib82","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1586\/17512433.2015.1091302","article-title":"The effect of antiepileptic drugs on thyroid hormonal function: Causes and implications","volume":"8","author":"Hamed","year":"2015","journal-title":"Expert Rev Clinical Pharmacol"},{"key":"10.1016\/j.spen.2017.10.005_bib83","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.seizure.2003.12.006","article-title":"Epilepsy and erectile dysfunction: A review","volume":"13","author":"Smaldon","year":"2013","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.spen.2017.10.005_bib84","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1212\/01.WNL.0000098936.46730.64","article-title":"Effect of epilepsy and antiepileptic drugs on male reproductive health","volume":"62","author":"Isoj\u00e4rvi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.10.005_bib85","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0015-0282(16)54234-4","article-title":"Abnormal pattern of luteinizing hormone pulsatility in women with epilepsy","volume":"55","author":"Bilo","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.spen.2017.10.005_bib86","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archneur.1986.00520040029014","article-title":"Reproductive endocrine disorders in women with partial seizures of temporal lobe origin","volume":"43","author":"Herzog","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1016\/j.spen.2017.10.005_bib87","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/09513599409058035","article-title":"Reduced fertility and neuroendocrine dysfunction in women with epilepsy","volume":"8","author":"Nappi","year":"1994","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.spen.2017.10.005_bib88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10072-006-0675-y","article-title":"Epilepsy and polycystic ovary syndrome: where is the link?","volume":"27","author":"Bilo","year":"2006","journal-title":"Neurol Sci"},{"key":"10.1016\/j.spen.2017.10.005_bib89","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1196\/annals.1429.030","article-title":"Menstrual cycle dysfunction associated with neurologic and psychiatric disorders. Their treatment in adolescents","volume":"1135","author":"Joffe","year":"2008","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"10.1016\/j.spen.2017.10.005_bib90","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.73.2.121","article-title":"Reproductive dysfunction in women with epilepsy: Recommendations for evaluation and management","volume":"73","author":"Bauer","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.spen.2017.10.005_bib91","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1528-1157.2000.tb00119.x","article-title":"Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE)","volume":"41","author":"Arpino","year":"2000","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.spen.2017.10.005_bib92","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","article-title":"Practice parameter update: Management issues for women with epilepsy\u2014Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117301237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117301237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T18:29:56Z","timestamp":1535308196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909117301237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1071909117301237"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2017.10.005","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone Health and Endocrine Comorbidities in Pediatric Epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2017.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}